Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Interventional Trial of Ovarian Function Suppression for Breast Cancer (OFS)

NCT07158021 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT07158021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07158021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Interventional Trial of Ovarian Function Suppression for Breast Cancer (OFS)
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
January 22, 2026
Completion date
January 1, 2028
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage i breast cancer ajcc v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iii breast cancer ajcc v8, anatomic stage iv breast cancer ajcc v8, metastatic breast carcinoma